» Articles » PMID: 22580739

Combined Administration of Anisodamine and Neostigmine Produces Anti-shock Effects: Involvement of α7 Nicotinic Acetylcholine Receptors

Overview
Specialty Pharmacology
Date 2012 May 15
PMID 22580739
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate the anti-effects of anisodamine and neostigmine in animal models of endotoxic and hemorrhagic shock.

Methods: Kunming mice were injected with lipopolysaccharide (LPS 30 mg/kg, ip) to induce endotoxic shock. Anisodamine (12.5, 25, and 50 mg/kg, ip) and neostigmine (12.5, 25, and 50 μg/kg, ip) were administered immediately after LPS injection. Survival rate was monitored, and the serum levels of TNF-α and IL-1β were analyzed using ELISA assays. The effects of anisodamine and neostigmine were also examined in α7 nicotinic acetylcholine receptor (α7 nAChR) knockout mice with endotoxic shock and in Beagle dogs with hemorrhagic shock.

Results: In mice with experimental endotoxemia, combined administration of anisodamine and neostigmine significantly increased the survival rate and decreased the serum levels of inflammatory cytokines, as compared to those produced by either drug alone. The anti-shock effect of combined anisodamine and neostigmine was abolished in α7 nAChR knockout mice. On the other hand, intravenous injection of the combined anisodamine and neostigmine, or the selective α7 nAChR agonist PNU282987 exerted similar anti-shock effects in dogs with hemorrhagic shock.

Conclusion: The results demonstrate that combined administration of anisodamine and neostigmine produces significant anti-shock effects, which involves activation of α7 nAChRs.

Citing Articles

Combined administration of anisodamine and neostigmine alleviated colitis by inducing autophagy and inhibiting inflammation.

Liu M, Zhu D, Yan H, Dong Z, Zhang J, Kong N PLoS One. 2024; 19(2):e0291543.

PMID: 38354108 PMC: 10866466. DOI: 10.1371/journal.pone.0291543.


New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength.

Si S, Zhao X, Su F, Lu H, Zhang D, Sun L Front Pharmacol. 2023; 14:1227496.

PMID: 37601044 PMC: 10436336. DOI: 10.3389/fphar.2023.1227496.


Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial.

El-Tamalawy M, Soliman M, Omara A, Rashad A, Ibrahim O, El-Shishtawy M Front Pharmacol. 2022; 13:855764.

PMID: 35330830 PMC: 8940304. DOI: 10.3389/fphar.2022.855764.


Therapeutic Effect of Combining Anisodamine With Neostigmine on Local Scar Formation Following Roux-en-Y Choledochojejunostomy in a Novel Rat Model.

Lyu S, Wang J, Xu W, Wang H, Pan F, Jiang T Front Pharmacol. 2021; 12:700050.

PMID: 34658849 PMC: 8511430. DOI: 10.3389/fphar.2021.700050.


New Pathways for the Skin's Stress Response: The Cholinergic Neuropeptide SLURP-1 Can Activate Mast Cells and Alter Cytokine Production in Mice.

Ertle C, Rommel F, Tumala S, Moriwaki Y, Klein J, Kruse J Front Immunol. 2021; 12:631881.

PMID: 33815383 PMC: 8012551. DOI: 10.3389/fimmu.2021.631881.


References
1.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B . Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2002; 345(19):1368-77. DOI: 10.1056/NEJMoa010307. View

2.
Wang S, KUO N . Experience in emergency treatment of shock due to infection. Chin Med J (Engl). 1978; 4(6):497-500. View

3.
Guarini S, Altavilla D, Cainazzo M, Giuliani D, Bigiani A, Marini H . Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation. 2003; 107(8):1189-94. DOI: 10.1161/01.cir.0000050627.90734.ed. View

4.
Bruegger D, Kemming G, Jacob M, Meisner F, Wojtczyk C, Packert K . Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions. Crit Care. 2007; 11(6):R130. PMC: 2246228. DOI: 10.1186/cc6200. View

5.
. Studies on microcirculation in Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Microvasc Res. 1980; 20(3):371-3. DOI: 10.1016/0026-2862(80)90065-5. View